Notably, oxaliplatin exhibited excellent tumor growth suppression in HT29 Oxa-R-KO xenograft as compared to REV7 proficient HT29 Oxa-R xenograft with no significant difference in body weight (Fig. 6a–d). Here, MAD2L2 is linked to neoplasm.